What type of breast show more risk of cancer rejuvenation - those with dense or less dense issues? A new study separates the two
Tuesday, 23 April 2013
A new study shows for the first time that researchers have been able to
predict which women are at greater risk of breast cancer recurrence
based on the nature of their breast composition. They have reviewed the
effects of the drug tamoxifen on breast tissues, and determine that the
denser the breast tissue, the greater the risk of cancer recurrence.
This comes from a new study led by the Swedish researcher, Professor
Per Hall of Karolinska Institutet who, in a new study published in the
Journal of Clinical Oncology, according to radio Sweden, determine that
two types of breast tissues reveal two lines of cure for the disease.
"What we have found is that after a woman had surgery for breast cancer
and treated with an anti-hormone called Tamoxifen, it decreases the
density of breast tissue, ie, the white part of the mammogram image,"
said Per Hall to radio Sweden.
Scientists have discovered that the more the density decreases, the
less risk that she'll regains breast cancer. The preventive cancer drug
Tamoxifen is given today to women treated for breast tumours. The agent
works by reducing the density of the breast and given over several
years. But the drug does not provide a protective effect in all women.
In the new study, researchers have compared breast density in women who took tamoxifen for one year.
The results show that those who still had dense breasts, despite
medication, were twice as likely to die from breast cancer, compared
with those whose breast density had decreased, reports radio Sweden.
by Scancomark.com Team